Table 1.
Before MAK3 | After MAK3 | |||
---|---|---|---|---|
IL-8 | elastase * | IL-8† | elastase ‡ | |
Patient no. | (pg/μmol creat.) | (ng/μmol creat.) | (pg/μmol creat.) | (ng/μmol creat.) |
1 | 0 | 0 | 8 | 179 |
2 | 82·4 | 1526·5 | 198·7 | 4207·1 |
3 | 0 | 0 | 14·6 | 0 |
5 | 42·3 | 445·8 | 96·8 | 1017·3 |
6 | 0 | 0 | 27·4 | 172·8 |
7 | 16·1 | 127·3 | 41·6 | 589·9 |
8 | 3·5 | 43·1 | 17·6 | 226·1 |
10 | 0 | 0 | 10·4 | 0 |
11 | 0 | 0 | 18·7 | 183·4 |
13 | 0 | 40·9 | 3·2 | 246·4 |
14 | 52·5 | 364·3 | 2·3 | 0 |
15 | 0 | 0 | 187·5 | 98·4 |
A correlation was observed between elastase and IL-8 (τ = 0·898; P < 0·0001).
Significant difference compared with the level before MAK3 (P = 0·006 sign test).
Significant difference compared with the level before MAK3 (P = 0·02 sign test).